N
Niki Karavitaki
Researcher at University of Birmingham
Publications - 175
Citations - 7702
Niki Karavitaki is an academic researcher from University of Birmingham. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 40, co-authored 147 publications receiving 6071 citations. Previous affiliations of Niki Karavitaki include University Hospitals Birmingham NHS Foundation Trust & Queen Mary University of London.
Papers
More filters
Journal ArticleDOI
Opioids and pituitary function: expert opinion
Mônica R. Gadelha,Niki Karavitaki,Jeffrey Fudin,Jeffrey Bettinger,Hershel Raff,Anat Ben-Shlomo +5 more
TL;DR: Clinical and biochemical evaluation is recommended for potential central adrenal insufficiency, central hypogonadism, and/or hyperprolactinemia in patients chronically treated with opioids as well as the use of current expert guidelines for the diagnosis and treatment of these conditions.
Journal ArticleDOI
Disconnection hyperprolactinaemia in nonadenomatous sellar/parasellar lesions practically never exceeds 2000 mU/l
Journal ArticleDOI
Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
TL;DR: The coexistence of systemic IGF-I hypersecretion with a quick progression in the histopathological grade of the astrocytoma raises the compelling question of whether the clinical behavior of theAstrocytic tumor was influenced by the acromegalic status.
Journal ArticleDOI
A rare challenging case of co-existent craniopharyngioma, acromegaly and squamous cell lung cancer.
Athanasios Fountas,Shu Teng Chai,Shu Teng Chai,Shu Teng Chai,John Ayuk,Neil Gittoes,Neil Gittoes,Neil Gittoes,Swarupsinh Chavda,Niki Karavitaki,Niki Karavitaki,Niki Karavitaki +11 more
TL;DR: A 65-year-old man presented with visual deterioration, fatigue and frontal headaches, and pathology of the specimen was diagnostic of adamantinomatous craniopharyngioma, and aetiopathogenic link between these two conditions is unlikely.
Journal ArticleDOI
Histopathology of Parasellar Neoplasms.
TL;DR: In this paper, the authors present histopathological and molecular genetic features, updated classification criteria and recent advances in the diagnostics and rationale for novel pharmacological therapies of selected types of parasellar neoplasms.